All treatments
Treatment
Calquence 100 mg film-coated tablets clinical trials
3 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic exploratory (Phase II)
SAKK 38/19: Assessing a ctDNA and PET-oriented therapy in patients with DLBCL. A multicenter, open-label, phase II trial
This study is looking at a new treatment called Calquence for a type of blood cancer called large B-cell lymphoma. It aims to see how well Calquence stops the cancer from growing and if it helps patients achieve complete remission.
For: Disseminated large B-cell lymphomaItaly - Ongoing, recruitingTherapeutic exploratory (Phase II)
CLL-Frail - A prospective, multicenter phase II trial of acalabrutinib in very old (≥80y) or frail CLL-Patients
This study looks at a medicine called Calquence for older or weaker patients with a type of blood cancer called CLL. It's for people who haven't had treatment before or whose cancer has come back. We want to see how well the medicine works after about six months.
For: treatment-naïve or relapsed/refractory chronic lymphocytic leukemiaAustria · Germany - Ongoing, recruitingTherapeutic exploratory (Phase II)
An Open-label, Phase 2 Study of ACP-196 in Subjects with Mantle Cell Lymphoma
This study looks at a new drug, Calquence, for adults with a type of blood cancer called Mantle Cell Lymphoma. Researchers want to see how many people respond to the treatment and how safe it is.
For: Mantle Cell LymphomaPoland · France